Evidence map›Paper›PMID 36832006›Full record

ArticleBiosensors2023

A Magnetoelectrochemical Bioassay for Highly Sensitive Sensing of Point Mutations in Interleukin-6 Gene Using TMB as a Hybridization Intercalation Indicator.

Sabrine Baachaoui, Mohamed Mastouri, Maroua Meftah, Basma Yaacoubi-Loueslati, Noureddine Raouafi

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sabrine BaachaouiSensors and Biosensors Group, Laboratory of Analytical Chemistry and Electrochemistry (LR99ES15), Chemistry Department, Faculty of Science, University of Tunis El Manar, Tunis 2092, Tunisia.
Mohamed MastouriSensors and Biosensors Group, Laboratory of Analytical Chemistry and Electrochemistry (LR99ES15), Chemistry Department, Faculty of Science, University of Tunis El Manar, Tunis 2092, Tunisia.
Maroua MeftahSensors and Biosensors Group, Laboratory of Analytical Chemistry and Electrochemistry (LR99ES15), Chemistry Department, Faculty of Science, University of Tunis El Manar, Tunis 2092, Tunisia.
Basma Yaacoubi-LoueslatiLaboratory of Mycology, Pathologies and Biomarkers (LR16ES15), Biology Department, Faculty of Science, University of Tunis El Manar, Tunis 2092, Tunisia.
Noureddine RaouafiSensors and Biosensors Group, Laboratory of Analytical Chemistry and Electrochemistry (LR99ES15), Chemistry Department, Faculty of Science, University of Tunis El Manar, Tunis 2092, Tunisia.ORCID 0000-0001-8938-8221
Tunis El Manar University · TN

Funding

Ministry of Higher Education and Scientific Research PRF2017-D4P1
6 · The paper itself

Abstract

Point mutations are common in the human DNA genome and are closely related to higher susceptibility to cancer diseases. Therefore, suitable methods for their sensing are of general interest. In this work, we report on a magnetic electrochemical bioassay using DNA probes tethered to streptavidin magnetic beads (strep-MBs) to detect T > G single nucleotide polymorphism (SNP) within the inteleukin-6 (IL6) gene in human genomic DNA. In the presence of the target DNA fragment and tetramethylbenzidine (TMB), the electrochemical signal related to the oxidation of TMB is observed, which is much higher than the one obtained in the absence of the target. The key parameters affecting the analytical signal, such as the concentration of the biotinylated probe, its incubation time with strep-MBs, DNA hybridization time, and TMB loading, were optimized using the electrochemical signal intensity and signal-to-blank (S/B) ratio as selection criteria. Using spiked buffer solutions, the bioassay can detect the mutated allele in a wide range of concentrations (over six decades) with a low detection limit (7.3 fM). Furthermore, the bioassay displays a high specificity with high concentrations of the major allele (one mismatched), and two mismatched and non-complementary DNA. More importantly, the bioassay can detect the variation in scarcely diluted human DNA, collected from 23 donors, and can reliably distinguish between heterozygous (TG genotype) and homozygous (GG genotype) in respect to the control subjects (TT genotype), where the differences are statistically highly significant (

Indexed as

Biosensing TechniquesInterleukin-6DNADNA ProbesHumansNucleic Acid HybridizationPoint MutationStreptavidinDNADNA ProbesInterleukin-6Streptavidincancerelectrochemistryhuman DNAinterleukin-6ovarian cancerpoint mutationsensing

Identifiers

PMID36832006
PMCPMC9954083
OpenAlexW4319598705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.